• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMJ Glob Health . The epidemiology and outcomes of adults with acute hypoxaemic respiratory failure in a low-income country in the context of the C

tetano

Editor, Senior Moderator
BMJ Glob Health


. 2025 Aug 17;10(8):e017949.
doi: 10.1136/bmjgh-2024-017949. The epidemiology and outcomes of adults with acute hypoxaemic respiratory failure in a low-income country in the context of the COVID-19 pandemic: a prospective, observational, multicentre cohort study

Arthur Kwizera[SUP] 1 [/SUP], Daphne Kabatoro[SUP] 2 [/SUP], Cornelius Sendagire[SUP] 2 [/SUP], Jane Nakibuuka[SUP] 3 4 [/SUP], Darius Owachi[SUP] 3 [/SUP], Christopher Nsereko[SUP] 5 [/SUP], John Paul Ochieng[SUP] 6 [/SUP], Maria Goretti Nampiina[SUP] 7 [/SUP], Mary Jane Nampaawu[SUP] 8 [/SUP], Dennis Kakaire[SUP] 9 [/SUP], Morris Baluku[SUP] 10 [/SUP], Eric Odwar[SUP] 11 [/SUP], George Kateregga[SUP] 12 [/SUP], Martin Duenser[SUP] 13 [/SUP], Charles Olaro[SUP] 14 [/SUP], Henry Kyobe-Bosa[SUP] 15 16 [/SUP], Bruce J Kirenga[SUP] 2 [/SUP], Lydia Nakiyingi[SUP] 2 [/SUP], Pauline Byakika-Kibwika[SUP] 17 [/SUP], Noah Kiwanuka[SUP] 18 [/SUP], David Patrick Kateete[SUP] 19 [/SUP], Moses Joloba[SUP] 20 [/SUP], Charlotte Summers[SUP] 21 [/SUP]; ARISE-Uganda Investigators



Affiliations
Abstract

Background: Few data regarding the incidence and outcomes of acute hypoxaemic respiratory failure (AHRF) in low- and middle-income countries exist.
Methods: We undertook a prospective, observational multicentre study at 11 Ugandan hospitals (July 2020-April 2021) to determine the prevalence, aetiology and 28-day all-cause mortality of AHRF (acute shortness of breath plus peripheral oxygen saturation <91% while breathing ambient air) in adults (≥18 years) who required unplanned hospitalisation.
Findings: 16 747 adults required unplanned hospitalisation during the study period. The median age of study participants was 50 years, and 65.1% were male. The prevalence of AHRF was 4.1%. The predominant causes were pulmonary (46.8%) and extrapulmonary infection (18.3%). Only 38 patients (5.6%) received invasive mechanical ventilation. All-cause mortality 28 days after hospitalisation was 37.9% and associated with the severity of hypoxaemia at presentation (p<0.001). Risk factors for death included oxygen saturation (adjusted relative risk (aRR) 0.96 (95% CI 0.93 to 0.98); p=0.001), the lung injury prediction score (aRR 1.83 (95% CI 1.43 to 2.36); p<0.001), respiratory rate>30 breaths per minute (aRR 2.39 (95% CI 1.34 to 4.26); p=0.003) and age >65 years (aRR 2.09 (95% CI 1.13 to 2.86); p=0.02).
Interpretation: In the context of the COVID-19 pandemic, the prevalence of AHRF among adults requiring unplanned hospitalisation in Uganda was comparable with that reported by previous single-centre studies. Pulmonary infection was the most common cause of AHRF. The high 28-day mortality may be explained by the severity of the disease at presentation and the limited access to advanced organ support, including invasive mechanical ventilation.

Keywords: Cohort study; Epidemiology; Health systems.

 
Back
Top Bottom